Molecular Docking of 3,7-Dihydroxy-2-phenyl-4H-chromen-4-one as a LOX Inhibitory Compound

  • Taj Ur Rehman Department of Chemistry, Mohi-Udin Islamic University, AJ&K, Pakistan.
  • Muhammad Aurang Zeb Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, School of Chemical Science and Technology, Yunnan University, Kunming, Yunnan 650091, P.R China.
  • Wajiha Liaqat Institute of Chemical Sciences, University of Peshwar-25120, Pakistan.
  • Wei-Lie Xiao Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, School of Chemical Science and Technology, Yunnan University, Kunming, Yunnan 650091, P.R China.
Keywords: Millettia ovalifolia, 3,7-Dihydroxy-2-phenyl-4H-chromen-4-one, Lipoxygenase, Inflammation, Docking.

Abstract

The present study was carried out to explore phytochemically and pharmacologically the medicinal plant botanically classified as Millettia ovalifolia. The structure of the isolated compound 3,7-Dihydroxy-2-phenyl-4H-chromen-4-one was confirmed by modern spectroscopic techniques besides its comparison with analytical data available in literature. The compound was further studied for lipoxygenase (LOX) inhibitory activity and docking studies. The compound was found to reveal important LOX inhibitory potential with the IC50 value 31.92±0.02 μM.  The molecular docking study further showed the important molecular interactions between the compound and LOX displaying encouraging activity for more optimization as an approaching anti-inflammatory lead compound. The results showed that this plant is very significant and can act as a source to treat inflammation.

Published
2018-08-18
How to Cite
Rehman, T., Zeb, M., Liaqat, W., & Xiao, W.-L. (2018). Molecular Docking of 3,7-Dihydroxy-2-phenyl-4H-chromen-4-one as a LOX Inhibitory Compound. PSM Biological Research, 3(3), 120-124. Retrieved from https://journals.psmpublishers.org/index.php/biolres/article/view/211
Section
Short Communications